Nevertheless, the fact that in our study the expression of anti-apoptotic BCL-2 was not restored in repaired subclones suggests that enhanced ADCC after MYC modulation is not solely influenced by BCL-2, highlighting the multifaceted mechanisms of MYC to escape from anti-tumor immune responses. This evidence concerns the gene BCL2 and neoplasm.